ECLLA Members
ECLLA members are organisations and professionals from across Europe who share a commitment to improving equity in CLL care. Together, they collaborate, share knowledge and data, align advocacy efforts, and contribute to a unified European voice for people living with CLL.
LyLe mediates contact between patients
LyLe is a patient organisation for people affected by haematological cancers, whether directly as patients or indirectly as family members and carers.
Our aim is to provide patients, their relatives and everyone with an interest in haematological diseases with accurate, up-to-date and reliable information. We are committed to empowering patients through education, supporting informed decision-making, and fostering a strong community by encouraging networking and the exchange of experiences among patients and their families.
Every year, approximately 2,600 people develop blood cancers such as lymphoma, leukemia or MDS. Once diagnosed, you need to talk to others who have been in the same situation and who have the same feelings and thoughts.
Lymphoma , leukemia and MDS are hematological diseases. The diseases are treated in the hematology departments of the hospitals. You can read more about the different diseases on our disease pages, in our large library and in our member magazines, LyLe Nyt and LyLe Fokus .
New strategy 2020
LyLe has a new strategy for 2020 : To create a framework for a stronger focus on the diseases we cover as an association. This will happen in a dynamic interaction between LyLe Nyt , our new website, lyle.dk, our social media platforms and a targeted welcome to new members of the association.
LyLe’s story
The history of the association is still short. We started at an information meeting in April 2007, where we asked those present about their expectations of a patient association. LyLe’s purpose and the association’s work are based on the dialogue at the meeting. For the first 10 years of LyLe’s history, we have had an informal collaboration with the Danish Cancer Society, and 2018 is the first year that LyLe works completely independently without any connection to the Danish Cancer Society .
Read the great interview with LyLe’s founder, Jytte Gamby, and get the story of how LyLe came to be . The interview was made in connection with LyLe’s 10th anniversary event in the fall of 2017.
You can also see an overview of highlights in LyLe’s 10-year history – also prepared in connection with LyLe’s anniversary in 2017. Overall, we work from 3 areas: Dialogue with others, information and influencing systems.
Dialogue with others
- Dialogue with others with the same disease, shortly after receiving the diagnosis.
- Dialogue with others during the treatment process.
- Dialogue with others after final treatment and focus on the late effects.
- Dialogue between relatives.
- Dialogue with professionals.
Information
- More general knowledge about the disease.
- Knowledge about the disease via pamphlets, etc., preferably with the information that occurs during the consultation, so that it is possible to retain and remember it.
- Knowledge about research.
- Knowledge of where to find more information about the diseases.
- Website.
Impact on systems
- Political influence in the healthcare system.
- More focus on lymphoma and leukemia.
- Possibility of a second opinion.
- The patient association should have a dialogue with the healthcare system.
Website: lyle.dk
